The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / E•••••••• B••••••••

S•••••• acquires E•••••••• B••••••••, further strengthening its strategic foothold in the US

Add-on acquisitionannouncedadd-onannounced Oct 25, 2022Fact
What happened
Platform
S••••••add-on basis: S•••••• acquires E•••••••• B••••••••, further strengthening its strategic foothold in the US | S•••••• is held by K•••••••• C•••••• on its portfolio page; published on K•••••••• C••••••'s own news page
Control
Control
Share acquired
unknown
Industry
healthcare / pharma
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • A••• K••••, Partner at K•••••••• C••••••, added: “Following the recent acquisition of Organix in the Boston area, the addition of E•••••••• B•••••••• in New Jersey marks another milestone in S••••••’ strategy to build a truly transatlantic business, serving the biopharma industry globally.
  • S••••••Platformconfirmed
    S•••••• acquires E•••••••• B••••••••, further strengthening its strategic foothold in the US | S•••••• is held by K•••••••• C•••••• on its portfolio page; published on K•••••••• C••••••'s own news page
  • S•••••• acquires E•••••••• B••••••••, further strengthening its strategic foothold in the US | S•••••• is held by K•••••••• C•••••• on its portfolio page; published on K•••••••• C••••••'s own news page
Side not stated
Evidence
S•••••• acquires E•••••••• B••••••••, further strengthening its strategic foothold in the US
S•••••• acquires E•••••••• B••••••••, further strengthening its strategic foothold in the | Private Equity Intelligence | DFX